1. Zheng Y, Yu Q, Lin Y, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis 2022;22:541–551.

3. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA 2003;290:1510–1514.

4. Wassermann A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenschr 1906;32:745–746.

5. Sweitzer S, Duncan JA, Seña AC. Update on syphilis diagnostics. Curr Opin Infect Dis 2025;38:44–53.

6. Papp JR, Park IU, Fakile Y, Pereira L, Pillay A, Bolan GA. CDC laboratory recommendations for syphilis testing, United States, 2024. MMWR Recomm Rep 2024;73:1–32.

7. Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol 2005;16:45–51.

8. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995;8:1–21.

9. Wang S, Kim S, Cho S, Kim HS, Min S. Introduction to the transition of mandatory surveillance system in the syphilis monitoring. Public Health Wkly Rep 2023;16:1620–1630. 16. Lee E, Kim J, Bang JH, Lee JY, Cho SI. Association of HIV-syphilis coinfection with optimal antiretroviral adherence: a nation- wide claims study. AIDS Care 2020;32:651–655.

18. Ministry of Health Labour Welfare. Annual trends in reported numbers of sexually transmitted diseases (STDs) by gender [Internet] Tokyo: Ministry of Health Labour Welfare, c2025. [cited 2025 Jul 3]. Available from: https://www.mhlw.go.jp/topics/2005/04/tp0411-1.html. 31. Satyaputra F, Hendry S, Braddick M, Sivabalan P, Norton R. The laboratory diagnosis of syphilis. J Clin Microbiol 2021;59:e0010021.

32. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021;70:1–187.

33. Cho SH, Choi HW, Choi R, Lee SG, Kee SJ. Annual report on the Korean Association of External Quality Assessment Service on serological tests for syphilis (2022–2023). Lab Med Qual Assur 2025;47:33–42.

34. Leroy AG, Robert M, Carpentier M, et al. Assessment of a fully automated RPR assay (Mediace RPR) for serological diagnosis and follow-up of syphilis: a retrospective study. Diagn Microbiol Infect Dis 2022;104:115767.

35. Tsuboi M, Nishijima T, Aoki T, et al. Usefulness of automated latex turbidimetric rapid plasma reagin test for diagnosis and evaluation of treatment response in syphilis in comparison with manual card test: a prospective cohort study. J Clin Microbiol 2018;56:e01003–18.

36. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991;114:1005–1009.

37. Haas JS, Bolan G, Larsen SA, Clement MJ, Bacchetti P, Moss AR. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis 1990;162:862–866.

38. Morshed MG, Singh AE. Recent trends in the serologic diagnosis of syphilis. Clin Vaccine Immunol 2015;22:137–147.

39. Loeffelholz MJ, Wen T, Patel JA. Analysis of bioplex syphilis IgG quantitative results in different patient populations. Clin Vaccine Immunol 2011;18:2005–2006.

40. Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011;204:1297–1304.

41. Wong EH, Klausner JD, Caguin-Grygiel G, et al. Evaluation of an IgM/IgG sensitive enzyme immunoassay and the utility of index values for the screening of syphilis infection in a high-risk population. Sex Transm Dis 2011;38:528–532.

42. Yen-Lieberman B, Daniel J, Means C, et al. Identification of false-positive syphilis antibody results using a semiquantitative algorithm. Clin Vaccine Immunol 2011;18:1038–1040.

43. Fakile YF, Jost H, Hoover KW, et al. Correlation of treponemal immunoassay signal strength values with reactivity of confirmatory treponemal testing. J Clin Microbiol 2017;56:e01165–17.

44. Prince HE, Marlowe EM, Schwab DA. Relationship between DiaSorin Liaison Treponema pallidum antibody indices and confirmatory assay results in the reverse syphilis testing algorithm. Diagn Microbiol Infect Dis 2021;100:115303.

45. Murai R, Yamada K, Yonezawa H, Yanagihara N, Takahashi S. Evaluation of new algorithm using TPLA as an initial syphilis screening test. J Infect Chemother 2019;25:68–70.

46. Cha YJ, Bae JH, Park Q, Chae SL. Annual report on the external quality assessment scheme of viral markers and serological tests for syphilis in Korea (2014). J Lab Med Qual Assur 2015;37:124–133.

47. Pham MD, Ong JJ, Anderson DA, Drummer HE, Stoové M. Point-of-care diagnostics for diagnosis of active syphilis infection: needs, challenges and the way forward. Int J Environ Res Public Health 2022;19:8172.

48. Bocoum FY, Ouédraogo H, Tarnagda G, et al. Evaluation of the diagnostic performance and operational characteristics of four rapid immunochromatographic syphilis tests in Burkina Faso. Afr Health Sci 2015;15:360–367.

49. Van Den Heuvel A, Smet H, Prat I, et al. Laboratory evaluation of four HIV/syphilis rapid diagnostic tests. BMC Infect Dis 2019;19:1.

50. Jafari Y, Peeling RW, Shivkumar S, Claessens C, Joseph L, Pai NP. Are Treponema pallidum specific rapid and point-of-care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta-analysis. PLoS One 2013;8:e54695.

51. Sabidó M, Benzaken AS, de-Andrade-Rodrigues EJ, Mayaud P. Rapid point-of-care diagnostic test for syphilis in high-risk populations, Manaus, Brazil. Emerg Infect Dis 2009;15:647–649.

52. Tsang RS, Shuel M, Hayden K, Van Caeseele P, Stein D. Laboratory evaluation of two point-of-care test kits for the identification of infectious syphilis. Can Commun Dis Rep 2022;48:82–88.

53. Holden J, Goheen J, Jett-Goheen M, Barnes M, Hsieh YH, Gaydos CA. An evaluation of the SD Bioline HIV/syphilis duo test. Int J STD AIDS 2018;29:57–62.

54. Leon SR, Ramos LB, Vargas SK, et al. Laboratory evaluation of a dual-path platform assay for rapid point-of-care HIV and syphilis testing. J Clin Microbiol 2016;54:492–494.

55. Bristow CC, Klausner JD, Tran A. Clinical test performance of a rapid point-of-care syphilis treponemal antibody test: a systematic review and meta-analysis. Clin Infect Dis 2020;71(Suppl 1):S52–S57.

56. Theel ES, Katz SS, Pillay A. Molecular and direct detection tests for treponema pallidum subspecies pallidum: a review of the literature, 1964–2017. Clin Infect Dis 2020;71(Suppl 1):S4–S12.

57. Gayet-Ageron A, Sednaoui P, Lautenschlager S, et al. Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis. Emerg Infect Dis 2015;21:127–129.

58. Grange PA, Gressier L, Dion PL, et al. Evaluation of a PCR test for detection of Treponema pallidum in swabs and blood. J Clin Microbiol 2012;50:546–552.

59. Aung ET, Fairley CK, Williamson DA, et al. Treponema pallidum detection at asymptomatic oral, anal, and vaginal sites in adults reporting sexual contact with persons with syphilis. Emerg Infect Dis 2023;29:2083–2092.

60. Seña AC, White BL, Sparling PF. Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010;51:700–708.

61. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986;104:368–376.

62. Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005–2006. MMWR Morb Mortal Wkly Rep 2008;57:872–875.

63. Cantor AG, Pappas M, Daeges M, Nelson HD. Screening for syphilis: updated evidence report and systematic review for the US preventive services task force. JAMA 2016;315:2328–2337.

64. Binnicker MJ, Jespersen DJ, Rollins LO. Direct comparison of the traditional and reverse syphilis screening algorithms in a population with a low prevalence of syphilis. J Clin Microbiol 2012;50:148–150.

65. Mishra S, Boily MC, Ng V, et al. The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the Greater Toronto Area. Sex Transm Dis 2011;38:190–196.

66. Centers for Disease Control and Prevention (CDC). Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006–2010. MMWR Morb Mortal Wkly Rep 2011;60:133–137.

67. Gottlieb SL, Pope V, Sternberg MR, et al. Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001–2004. Sex Transm Dis 2008;35:507–511.

68. Huh HJ, Chung JW, Park SY, Chae SL. Comparison of automated treponemal and nontreponemal test algorithms as first-line syphilis screening assays. Ann Lab Med 2016;36:23–27.

69. Huh HJ, Lee KK, Kim ES, Chae SL. Analysis of positive results in mediace rapid plasma reagin and Treponema pallidum latex agglutination as the automated syphilis test. Korean J Lab Med 2007;27:324–329Korean. 70. Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2021;35:574–588.

71. Kiołbasa M, Kaminiów K, Pastuszczak M. Serofast state after syphilis treatment: implications and recommendations for clinical practice. Narrative review. Postepy Dermatol Alergol 2025;42:215–220.

72. Tong ML, Lin LR, Liu GL, et al. Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One 2013;8:e70102.

73. Kazadi WM, Asiedu KB, Agana N, Mitjà O. Epidemiology of yaws: an update. Clin Epidemiol 2014;6:119–128.

74. Stamm LV. Pinta: Latin America’s forgotten disease? Am J Trop Med Hyg 2015;93:901–903.